A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors
Open Access
- 30 April 2012
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 18 (9), 2695-2703
- https://doi.org/10.1158/1078-0432.ccr-11-2210
Abstract
Purpose: Although the central role of the immune system for tumor prognosis is generally accepted, a single robust marker is not yet available.Keywords
Other Versions
This publication has 39 references indexed in Scilit:
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals Of Oncology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytesBritish Journal of Cancer, 2009
- Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer typesBritish Journal of Cancer, 2008
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular SubtypesClinical Cancer Research, 2008
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast CancerCancer Research, 2008
- The anticancer immune response: indispensable for therapeutic success?JCI Insight, 2008
- Immune surveillance: a balance between protumor and antitumor immunityCurrent Opinion in Genetics & Development, 2008
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002